No Data
No Data
Express News | Cytek Biosciences Showcases Its Patented Full Spectrum Profiling Technology at CYTO and IMMUNOLOGY2025
Cytek Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Maintains Target Price $8
The Price Is Right For Cytek Biosciences, Inc. (NASDAQ:CTKB) Even After Diving 26%
Express News | Stephens & Co. Reiterates Overweight on Cytek Biosciences, Maintains $6 Price Target